Items Tagged ‘Acute Lymphoblastic Leukemia’

September 5, 2017

FDA Approves Mylotarg for Treatment of Acute Myeloid Leukemia

By

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also approved Mylotarg for the treatment of patients aged 2 years and older with CD33-positive AML who have experienced a relapse or who […]

View full entry

Tags: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, AML, CD33 antigen, gemtuzumab ozogamicin, Leukemia, Mylotarg, News, Precision Cancer Medicine, targeted therapy


September 1, 2017

FDA Approves First Gene Therapy

By

CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases. The FDA […]

View full entry

Tags: Acute Lymphoblastic Leukemia, all, cell-based gene therapy, Kymriah, Leukemia, News, tisagenlecleucel


September 1, 2017

FDA Approves First Gene Therapy

By

CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia The U.S. Food and Drug Administration issued a historic action today making the first gene therapy available in the United States, ushering in a new approach to the treatment of cancer and other serious and life-threatening diseases. The FDA […]

View full entry

Tags: Acute Lymphoblastic Leukemia, all, cell-based gene therapy, Kymriah, Leukemia, News, tisagenlecleucel


May 19, 2015

Blincyto®

By

Class: Biological Therapy Generic Name: Blinatumomab Trade Name: Blincyto® For which conditions is this drug approved? Blincyto is approved for treatment of a certain type of acute lymphoblastic leukemia (ALL): Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute ALL. What is the mechanism of action? Blincyto is a type of drug known as a monoclonal […]

View full entry

Tags: Acute Lymphoblastic Leukemia, B, Biological Therapy, blincyto, Drug Dictionary


May 19, 2015

Blinatumomab

By

Class: Biological Therapy Generic Name: Blinatumomab Trade Name: Blincyto® For which conditions is this drug approved? Blincyto is approved for treatment of a certain type of acute lymphoblastic leukemia (ALL): Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute ALL. What is the mechanism of action? Blincyto is a type of drug known as a monoclonal […]

View full entry

Tags: Acute Lymphoblastic Leukemia, all, B, Biological Therapy, blincyto, Drug Dictionary


September 29, 2008

Survival Rates Improving in Childhood Hematologic Cancers

By

Survival Rates Improving in Childhood Hematologic Cancers Five- and 10-year survival rates in childhood hematalogic cancers have significantly improved since 1990, according to the results of a study recently published in the Journal of the National Cancer Institute. Approximately 40% of childhood cancers are classified as hematalogic cancers. Hematologic cancers are cancers of the blood […]

View full entry

Tags: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Stage Hodgkin's Lymphoma, Aggressive/Intermediate Grade Non-Hodgkin's Lymphoma, Early Stage Hodgkin's Lymphoma, Highly Aggressive/High Grade Non-Hodgkin's Lymphoma, Indolent/Low Grade Non-Hodgkin's Lymphoma


August 12, 2008

Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia

By

Injection of Umbilical Cord Stem Cells into Bone Appears Promising for Leukemia The injection of stem cells collected from umbilical cords into the pelvic bone of patients with leukemia appears promising; however, longer follow-up is necessary to determine outcomes for these patients. These results were recently published in an early online publication of the Lancet […]

View full entry

Tags: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Allogeneic Stem Cell Transplant